新興光學(00125.HK)年度擁有人應占虧損增加至3200萬港元
格隆匯6月27日丨新興光學(00125.HK)公吿,截至2025年3月31日止年度,集團的綜合營業額增加17.95%至828,000,000港元(2024年:702,000,000港元)。有關增幅乃由於集團的原設計製造(ODM)業務的可觀增長,反映加大營銷力度及建立多元化生產基地以迎合客户需要方面取得成功。
於回顧年內,集團的毛利率增加至11.32%(2024年:10.67%)。儘管如此,公司擁有人應占年度虧損增加至32,000,000港元(2024年:28,000,000港元),此乃由於利息收入及外匯收益減少,營銷、業務開發及行政費用增加,以及為提高勞動效率作出的重組支出所致。本年度每股基本虧損增加至12.27港仙(2024年:10.79港仙)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.